MENU
+Compare
VERV
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$5.75
Change
+$0.59 (+11.43%)
Capitalization
486.39M

VERV Verve Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for VERV with price predictions
Dec 20, 2024

VERV sees MACD Histogram crosses below signal line

VERV saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 13, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 28 instances where the indicator turned negative. In of the 28 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for VERV moved out of overbought territory on December 04, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 16, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on VERV as a result. In of 51 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

VERV moved below its 50-day moving average on December 16, 2024 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VERV broke above its upper Bollinger Band on December 02, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for VERV crossed bullishly above the 50-day moving average on December 03, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VERV advanced for three days, in of 171 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 70 cases where VERV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.956) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). VERV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (19.920) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VERV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VERV is expected to report earnings to rise 15.92% to -68 cents per share on February 26

Verve Therapeutics VERV Stock Earnings Reports
Q4'24
Est.
$-0.68
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.11
Q4'23
Beat
by $0.14
The last earnings report on November 05 showed earnings per share of -58 cents, beating the estimate of -68 cents. With 3.82M shares outstanding, the current market capitalization sits at 486.39M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 617 603-0070
Employees
255
Web
https://www.vervetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRYQX20.510.30
+1.48%
BNY Mellon Research Growth Y
OANLX80.131.11
+1.40%
Oakmark Select Institutional
TLAFX13.730.16
+1.18%
Transamerica Large Core ESG R4
PLJMX54.240.49
+0.91%
Putnam Research R6
FCGIX19.460.06
+0.31%
NYLI PineStone Global Equity Class I

VERV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+11.34%
BEAM - VERV
56%
Loosely correlated
+8.16%
CRSP - VERV
52%
Loosely correlated
+0.83%
NTLA - VERV
49%
Loosely correlated
+1.08%
EDIT - VERV
49%
Loosely correlated
-2.24%
PRME - VERV
48%
Loosely correlated
+4.66%
More